APO Research
Talk to an analyst

APO RESEARCH · REPORT

Irreversible Electroporation Ablators

Irreversible electroporation is a soft tissue ablation technique using ultra short but strong electrical fields to create permanent and hence lethal Nano pores in the cell membrane, to disrupt the cellular homeostasis. The resulting cell death results from apoptosis and not necrosis as in all other thermal or radiation based ablation techniques. The main use of IRE lies in tumor ablation in regions where precision and conservation of the extracellular matrix, blood flow and nerves are of importance. The technique is in an experimental stage and has not been approved for use outside of clinical trials. IRE is used in the NanoKnife System.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Irreversible electroporation is a soft tissue ablation technique using ultra short but strong electrical fields to create permanent and hence lethal Nano pores in the cell membrane, to disrupt the cellular homeostasis. The resulting cell death results from apoptosis and not necrosis as in all other thermal or radiation based ablation techniques. The main use of IRE lies in tumor ablation in regions where precision and conservation of the extracellular matrix, blood flow and nerves are of importance. The technique is in an experimental stage and has not been approved for use outside of clinical trials. IRE is used in the NanoKnife System.

Selected research

Market Outlook & Growth Opportunities

Global Irreversible Electroporation Ablators Market Outlook and Growth Opportunities 2026

21 December 2025194 pages

Choose your research edition.

Industry ResearchIrreversible Electroporation Ablators Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Irreversible Electroporation Ablators Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Irreversible Electroporation Ablators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Irreversible Electroporation Ablators Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Irreversible Electroporation Ablators Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Irreversible electroporation is a soft tissue ablation technique using ultra short but strong electrical fields to create permanent and hence lethal Nano pores in the cell membrane, to disrupt the cellular homeostasis. The resulting cell death results from apoptosis and not necrosis as in all other thermal or radiation based ablation techniques. The main use of IRE lies in tumor ablation in regions where precision and conservation of the extracellular matrix, blood flow and nerves are of importance. The technique is in an experimental stage and has not been approved for use outside of clinical trials. IRE is used in the NanoKnife System.

The world's leading manufacturers of irreversible electroporation ablators are AngioDynamics and Pulse Biosciences. North America is the largest consumption place, with a consumption market share nearly 56%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.

This report provides an overview of the global Irreversible Electroporation Ablators market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Irreversible Electroporation Ablators and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Irreversible Electroporation Ablators sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Irreversible Electroporation Ablators market size, projected growth trends, production technologies, key applications, and end-use industries.

Irreversible Electroporation Ablators Segment by Company

AngioDynamics

Pulse Biosciences

Irreversible Electroporation Ablators Segment by Type

Generator

Part

Service

Irreversible Electroporation Ablators Segment by Application

Liver

Pancreas

Prostate

Others

Irreversible Electroporation Ablators Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Irreversible Electroporation Ablators status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Irreversible Electroporation Ablators market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Irreversible Electroporation Ablators significant trends, drivers, influence factors in global and regions.

6. To analyze Irreversible Electroporation Ablators competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Irreversible Electroporation Ablators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Irreversible Electroporation Ablators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Irreversible Electroporation Ablators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Irreversible Electroporation Ablators market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Irreversible Electroporation Ablators industry.

Chapter 3: Detailed analysis of Irreversible Electroporation Ablators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Irreversible Electroporation Ablators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Irreversible Electroporation Ablators in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Irreversible Electroporation Ablators Industry Trends Table 2. Irreversible Electroporation Ablators Industry Drivers Table 3. Irreversible Electroporation Ablators Industry Opportunities and Challenges Table 4. Irreversible Electroporation Ablators Industry Restraints Table 5. Global Irreversible Electroporation Ablators Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Irreversible Electroporation Ablators Revenue Share by Company (2021-2026) Table 7. Global Irreversible Electroporation Ablators Sales Volume by Company (k units) & (2021-2026) Table 8. Global Irreversible Electroporation Ablators Sales Volume Share by Company (2021-2026) Table 9. Global Irreversible Electroporation Ablators Average Price (K USD/unit) of Company (2021-2026) Table 10. Global Irreversible Electroporation Ablators Company Ranking, (2024-2026) & (USD Million) Table 11. Global Irreversible Electroporation Ablators Key Company Manufacturing Base & Headquarters Table 12. Global Irreversible Electroporation Ablators Company, Product Type & Application Table 13. Global Irreversible Electroporation Ablators Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Irreversible Electroporation Ablators by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Generator Table 18. Significant Companies of Part Table 19. Significant Companies of Service Table 20. Global Irreversible Electroporation Ablators Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Irreversible Electroporation Ablators Sales Volume by Type (2021-2026) & (k units) Table 22. Global Irreversible Electroporation Ablators Sales Volume by Type (2027-2032) & (k units) Table 23. Global Irreversible Electroporation Ablators Sales Volume Share by Type (2021-2026) Table 24. Global Irreversible Electroporation Ablators Sales Volume Share by Type (2027-2032) Table 25. Global Irreversible Electroporation Ablators Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Irreversible Electroporation Ablators Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Irreversible Electroporation Ablators Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Irreversible Electroporation Ablators Sales Value Share by Type (2021-2026) Table 29. Global Irreversible Electroporation Ablators Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Liver Table 31. Significant Companies of Pancreas Table 32. Significant Companies of Prostate Table 33. Significant Companies of Others Table 34. Global Irreversible Electroporation Ablators Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Irreversible Electroporation Ablators Sales Volume by Application (2021-2026) & (k units) Table 36. Global Irreversible Electroporation Ablators Sales Volume by Application (2027-2032) & (k units) Table 37. Global Irreversible Electroporation Ablators Sales Volume Share by Application (2021-2026) Table 38. Global Irreversible Electroporation Ablators Sales Volume Share by Application (2027-2032) Table 39. Global Irreversible Electroporation Ablators Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Irreversible Electroporation Ablators Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Irreversible Electroporation Ablators Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Irreversible Electroporation Ablators Sales Value Share by Application (2021-2026) Table 43. Global Irreversible Electroporation Ablators Sales Value Share by Application (2027-2032) Table 44. Global Irreversible Electroporation Ablators Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Irreversible Electroporation Ablators Sales by Region (2021-2026) & (k units) Table 46. Global Irreversible Electroporation Ablators Sales Market Share by Region (2021-2026) Table 47. Global Irreversible Electroporation Ablators Sales by Region (2027-2032) & (k units) Table 48. Global Irreversible Electroporation Ablators Sales Market Share by Region (2027-2032) Table 49. Global Irreversible Electroporation Ablators Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Irreversible Electroporation Ablators Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Irreversible Electroporation Ablators Sales Value Share by Region (2021-2026) Table 52. Global Irreversible Electroporation Ablators Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Irreversible Electroporation Ablators Sales Value Share by Region (2027-2032) Table 54. Global Irreversible Electroporation Ablators Market Average Price (K USD/unit) by Region (2021-2026) Table 55. Global Irreversible Electroporation Ablators Market Average Price (K USD/unit) by Region (2027-2032) Table 56. Global Irreversible Electroporation Ablators Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Irreversible Electroporation Ablators Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Irreversible Electroporation Ablators Sales by Country (2021-2026) & (k units) Table 59. Global Irreversible Electroporation Ablators Sales Market Share by Country (2021-2026) Table 60. Global Irreversible Electroporation Ablators Sales by Country (2027-2032) & (k units) Table 61. Global Irreversible Electroporation Ablators Sales Market Share by Country (2027-2032) Table 62. Global Irreversible Electroporation Ablators Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Irreversible Electroporation Ablators Sales Value Market Share by Country (2021-2026) Table 64. Global Irreversible Electroporation Ablators Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Irreversible Electroporation Ablators Sales Value Market Share by Country (2027-2032) Table 66. AngioDynamics Company Information Table 67. AngioDynamics Business Overview Table 68. AngioDynamics Irreversible Electroporation Ablators Sales (k units), Value (US$ Million), Price (K USD/unit) and Gross Margin (2021-2026) Table 69. AngioDynamics Irreversible Electroporation Ablators Product Portfolio Table 70. AngioDynamics Recent Development Table 71. Pulse Biosciences Company Information Table 72. Pulse Biosciences Business Overview Table 73. Pulse Biosciences Irreversible Electroporation Ablators Sales (k units), Value (US$ Million), Price (K USD/unit) and Gross Margin (2021-2026) Table 74. Pulse Biosciences Irreversible Electroporation Ablators Product Portfolio Table 75. Pulse Biosciences Recent Development Table 76. Key Raw Materials Table 77. Raw Materials Key Suppliers Table 78. Irreversible Electroporation Ablators Distributors List Table 79. Irreversible Electroporation Ablators Customers List Table 80. Research Programs/Design for This Report Table 81. Authors List of This Report Table 82. Secondary Sources Table 83. Primary Sources List of Figures Figure 1. Irreversible Electroporation Ablators Product Image Figure 2. Global Irreversible Electroporation Ablators Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Irreversible Electroporation Ablators Sales Value (2021-2032) & (US$ Million) Figure 4. Global Irreversible Electroporation Ablators Sales (2021-2032) & (k units) Figure 5. Global Irreversible Electroporation Ablators Sales Average Price (K USD/unit) & (2021-2032) Figure 6. Global Irreversible Electroporation Ablators Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Generator Image Figure 10. Part Image Figure 11. Service Image Figure 12. Global Irreversible Electroporation Ablators Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Irreversible Electroporation Ablators Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Irreversible Electroporation Ablators Sales Volume Share by Type (2021-2032) Figure 15. Global Irreversible Electroporation Ablators Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Irreversible Electroporation Ablators Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Irreversible Electroporation Ablators Sales Value Share by Type (2021-2032) Figure 18. Liver Image Figure 19. Pancreas Image Figure 20. Prostate Image Figure 21. Others Image Figure 22. Global Irreversible Electroporation Ablators Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Irreversible Electroporation Ablators Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Irreversible Electroporation Ablators Sales Volume Share by Application (2021-2032) Figure 25. Global Irreversible Electroporation Ablators Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Irreversible Electroporation Ablators Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Irreversible Electroporation Ablators Sales Value Share by Application (2021-2032) Figure 28. Global Irreversible Electroporation Ablators Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Irreversible Electroporation Ablators Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Irreversible Electroporation Ablators Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Irreversible Electroporation Ablators Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Irreversible Electroporation Ablators Sales Value (2021-2032) & (US$ Million) Figure 33. North America Irreversible Electroporation Ablators Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Irreversible Electroporation Ablators Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Irreversible Electroporation Ablators Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Irreversible Electroporation Ablators Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Irreversible Electroporation Ablators Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Irreversible Electroporation Ablators Sales Value (2021-2032) & (US$ Million) Figure 39. South America Irreversible Electroporation Ablators Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Irreversible Electroporation Ablators Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Irreversible Electroporation Ablators Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Irreversible Electroporation Ablators Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Irreversible Electroporation Ablators Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Generator
  • Part
  • Service
Applications
  • Liver
  • Pancreas
  • Prostate
  • Others
Companies covered
  • AngioDynamics
  • Pulse Biosciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Irreversible Electroporation Ablators Sales Value (2021-2032)
  4. 1.2.2 Global Irreversible Electroporation Ablators Sales Volume (2021-2032)
  5. 1.2.3 Global Irreversible Electroporation Ablators Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Irreversible Electroporation Ablators Market Dynamics
  1. 2.1 Irreversible Electroporation Ablators Industry Trends
  2. 2.2 Irreversible Electroporation Ablators Industry Drivers
  3. 2.3 Irreversible Electroporation Ablators Industry Opportunities and Challenges
  4. 2.4 Irreversible Electroporation Ablators Industry Restraints
3 Irreversible Electroporation Ablators Market by Company
  1. 3.1 Global Irreversible Electroporation Ablators Company Revenue Ranking in 2025
  2. 3.2 Global Irreversible Electroporation Ablators Revenue by Company (2021-2026)
  3. 3.3 Global Irreversible Electroporation Ablators Sales Volume by Company (2021-2026)
  4. 3.4 Global Irreversible Electroporation Ablators Average Price by Company (2021-2026)
  5. 3.5 Global Irreversible Electroporation Ablators Company Ranking (2024-2026)
  6. 3.6 Global Irreversible Electroporation Ablators Company Manufacturing Base and Headquarters
  7. 3.7 Global Irreversible Electroporation Ablators Company Product Type and Application
  8. 3.8 Global Irreversible Electroporation Ablators Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Irreversible Electroporation Ablators Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Irreversible Electroporation Ablators Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Irreversible Electroporation Ablators Market by Type
  1. 4.1 Irreversible Electroporation Ablators Type Introduction
  2. 4.1.1 Generator
  3. 4.1.2 Part
  4. 4.1.3 Service
  5. 4.2 Global Irreversible Electroporation Ablators Sales Volume by Type
  6. 4.2.1 Global Irreversible Electroporation Ablators Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Irreversible Electroporation Ablators Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Irreversible Electroporation Ablators Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Irreversible Electroporation Ablators Sales Value by Type
  10. 4.3.1 Global Irreversible Electroporation Ablators Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Irreversible Electroporation Ablators Sales Value by Type (2021-2032)
  12. 4.3.3 Global Irreversible Electroporation Ablators Sales Value Share by Type (2021-2032)
5 Irreversible Electroporation Ablators Market by Application
  1. 5.1 Irreversible Electroporation Ablators Application Introduction
  2. 5.1.1 Liver
  3. 5.1.2 Pancreas
  4. 5.1.3 Prostate
  5. 5.1.4 Others
  6. 5.2 Global Irreversible Electroporation Ablators Sales Volume by Application
  7. 5.2.1 Global Irreversible Electroporation Ablators Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Irreversible Electroporation Ablators Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Irreversible Electroporation Ablators Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Irreversible Electroporation Ablators Sales Value by Application
  11. 5.3.1 Global Irreversible Electroporation Ablators Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Irreversible Electroporation Ablators Sales Value by Application (2021-2032)
  13. 5.3.3 Global Irreversible Electroporation Ablators Sales Value Share by Application (2021-2032)
6 Irreversible Electroporation Ablators Regional Sales and Value Analysis
  1. 6.1 Global Irreversible Electroporation Ablators Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Irreversible Electroporation Ablators Sales by Region (2021-2032)
  3. 6.2.1 Global Irreversible Electroporation Ablators Sales by Region: 2021-2026
  4. 6.2.2 Global Irreversible Electroporation Ablators Sales by Region (2027-2032)
  5. 6.3 Global Irreversible Electroporation Ablators Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Irreversible Electroporation Ablators Sales Value by Region (2021-2032)
  7. 6.4.1 Global Irreversible Electroporation Ablators Sales Value by Region: 2021-2026
  8. 6.4.2 Global Irreversible Electroporation Ablators Sales Value by Region (2027-2032)
  9. 6.5 Global Irreversible Electroporation Ablators Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Irreversible Electroporation Ablators Sales Value (2021-2032)
  12. 6.6.2 North America Irreversible Electroporation Ablators Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Irreversible Electroporation Ablators Sales Value (2021-2032)
  15. 6.7.2 Europe Irreversible Electroporation Ablators Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Irreversible Electroporation Ablators Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Irreversible Electroporation Ablators Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Irreversible Electroporation Ablators Sales Value (2021-2032)
  21. 6.9.2 South America Irreversible Electroporation Ablators Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Irreversible Electroporation Ablators Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Irreversible Electroporation Ablators Sales Value Share by Country, 2025 VS 2032
7 Irreversible Electroporation Ablators Country-level Sales and Value Analysis
  1. 7.1 Global Irreversible Electroporation Ablators Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Irreversible Electroporation Ablators Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Irreversible Electroporation Ablators Sales by Country (2021-2032)
  4. 7.3.1 Global Irreversible Electroporation Ablators Sales by Country (2021-2026)
  5. 7.3.2 Global Irreversible Electroporation Ablators Sales by Country (2027-2032)
  6. 7.4 Global Irreversible Electroporation Ablators Sales Value by Country (2021-2032)
  7. 7.4.1 Global Irreversible Electroporation Ablators Sales Value by Country (2021-2026)
  8. 7.4.2 Global Irreversible Electroporation Ablators Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Irreversible Electroporation Ablators Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Irreversible Electroporation Ablators Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Irreversible Electroporation Ablators Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AngioDynamics
  2. 8.1.1 AngioDynamics Company Information
  3. 8.1.2 AngioDynamics Business Overview
  4. 8.1.3 AngioDynamics Irreversible Electroporation Ablators Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AngioDynamics Irreversible Electroporation Ablators Product Portfolio
  6. 8.1.5 AngioDynamics Recent Developments
  7. 8.2 Pulse Biosciences
  8. 8.2.1 Pulse Biosciences Company Information
  9. 8.2.2 Pulse Biosciences Business Overview
  10. 8.2.3 Pulse Biosciences Irreversible Electroporation Ablators Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pulse Biosciences Irreversible Electroporation Ablators Product Portfolio
  12. 8.2.5 Pulse Biosciences Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Irreversible Electroporation Ablators Value Chain Analysis
  2. 9.1.1 Irreversible Electroporation Ablators Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Irreversible Electroporation Ablators Sales Mode & Process
  6. 9.2 Irreversible Electroporation Ablators Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Irreversible Electroporation Ablators Distributors
  9. 9.2.3 Irreversible Electroporation Ablators Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst